Plasmin alters the activity and quaternary structure of human plasma carboxypeptidase N

Biochemical Journal

Volumn 388, Issue 1, 2005, Pages 81-91

  Quagraine, Mercy O ^a   Tan, Fulong ^a   Tamei, Hironori ^a   Erdös, Ervin G ^a   Skidgel, Randal A ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Carboxypeptidase; Kininase I; Leucine rich repeat; Plasmin; Plasminogen activation; Proteolysis

Indexed keywords

CARBOXYPEPTIDASE N (CPN); CELL SURFACE PROTEINS; GEL FILTRATION; INCUBATION;

ASSAYS; CATALYSIS; CHEMICAL BONDS; DIMERS; FILTRATION; MOLECULAR STRUCTURE;

ENZYMES;

ARGININE CARBOXYPEPTIDASE; CELL SURFACE PROTEIN; DOCKING PROTEIN; PLASMIN; PLASMINOGEN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; ENZYME ACTIVE SITE; ENZYME STRUCTURE; GEL FILTRATION; HUMAN; HUMAN CELL; HYDROLYSIS; IMMUNOPRECIPITATION; PLASMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN QUATERNARY STRUCTURE; REGULATORY MECHANISM; SEQUENCE ANALYSIS; WESTERN BLOTTING;

AMINO ACID SEQUENCE; HUMANS; HYDROLYSIS; LYSINE CARBOXYPEPTIDASE; MOLECULAR SEQUENCE DATA; PLASMIN; PROTEIN STRUCTURE, QUATERNARY; PROTEIN SUBUNITS;

EID: 19544378667     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20041471     Document Type: Article

References (59)

1. Skidgel, R. A. (1996) Structure and function of mammalian zinc carboxypeptidases. In Zinc Metalloproteases in Health and Disease (Hooper, N. M., ed.), pp. 241-283, Taylor and Francis Ltd, London
2. Reznik, S. E. and Fricker, L. D. (2001) Carboxypeptidases from A to Z: implications in embryonic development and Wnt binding. Cell. Mol. Life Sci. 58, 1790-1804
3. Vendrell, J., Cuerol, E. and Aviles, F. X. (2000) Metallocarboxypeptidases and their protein inhibitors. Structure, function and biomedical properties. Biochim. Biophys. Acta 1477, 284-298
4. Skidgel, R. A. (1988) Basic carboxypeptidases: regulators of peptide hormone activity. Trends Pharmacol. Sci. 9, 299-304
5. Skidgel, R. A. and Erdös, E. G. (1998) Cellular carboxypeptidases. Immunol. Rev. 161, 129-41
6. Erdös, E. G. (1979) Kininases. Handb. Exp. Pharmacol. 25 (Suppl.), 427-487
7. Plow, E. F., Allampallam, K. and Redlitz A. (1997) The plasma carboxypeptidases and the regulation of the plasminogen system. Trends Cardiovasc. Med. 7, 71-75
8. Hendriks, D., Vingron, M., Vriend, G., Wang, W., Nalis, D. and Scharpe, S. (1993) On the specificity of carboxypeptidase N, a comparative study. Biol. Chem. Hoppe-Seyler 374, 843-849
9. Bouma, B. N., Marx, P. F., Mosnier, L. O. and Meijers, J. C. (2001) Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U). Thromb. Res. 101, 329-354
10. Nesheim, M., Wang, W., Boffa, M., Nagashima, M., Morser, J. and Bajzar, L. (1997) Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis. Thromb. Haemostasis 78, 386-391
11. Eaton, D. L., Malloy, B. E., Tsai, S. P., Henzel, W. and Drayna, D. (1991) Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma. J. Biol. Chem 266, 21833-21838
12. Erdös, E. G. and Sloane, E. M. (1962) An enzyme in human blood plasma that inactivates bradykinin and kallidins. Biochem. Pharmacol. 11, 582-592
13. Skidgel, R. A. and Erdös, E. G. (2004) Lysine carboxypeptidase. In Handbook of Proteolytic Enzymes, vol. 1 (Barrett, A. J., Rawlings, N. D. and Woessner, J. F., eds.), pp. 837-840, Academic Press, London
14. Oshima, G., Kato, J. and Erdös, E. G. (1975) Plasma carboxypeptidase N, subunits and characteristics. Arch. Biochem. Biophys. 170, 132-138
15. Oshima, G., Kato, J. and Erdös, E. G. (1974) Subunits of human plasma carboxypeptidase N (kininase I; anaphylatoxin inactivator). Biochim. Biophys. Acta 365, 344-348
16. Levin, Y., Skidgel, R. A. and Erdös, E. G (1982) Isolation and characterization of the subunits of human plasma carboxypeptidase N (kininase I). Proc. Natl. Acad. Sci U.S.A. 79, 4618-4622
17. Skidgel, R. A. (1995) Human carboxypeptidase N: lysine carboxypeptidase. Methods Enzymol. 248, 653-663
18. Tan, F., Jackman, H., Skidgel, R. A., Zsigmond, E. K. and Erdös, E. G. (1989) Protamine inhibits plasma carboxypeptidase N, the inactivator of anaphylatoxins and kinins. Anesthesiology 70, 267-275
19. Bokisch, V. A. and Müller-Eberhard, H. J. (1970) Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J. Clin. Invest. 49, 2427-2436
20. Mathews, K. P., Pan, P. M., Gardner, N. J. and Hugli, T. E. (1980) Familial carboxypeptidase N deficiency. Ann. Intern. Med. 93, 443-445
21. Cao, H. and Hegele, R. A. (2003) DNA polymorphism and mutations in CPN1, including the genomic basis of carboxypeptidase N deficiency. J. Hum. Genet. 48, 20-22
22. Ranby, M. (1982) Studies on the kinetics of plasminogen activation by tissue plasminogen activator. Biochim. Biophys. Acta 704, 451-469
23. Hoylaerts, M., Rijken, D. C., Lijnen, H. R. and Colien, D. (1982) Kinetics of the activation of plasminogen by human tissue plasminogen activator Role of fibrin. J. Biol. Chem. 257, 2912-2919
24. Redlitz A., Tan, A. K., Eaton, D. L. and Plow, E. F. (1995) Plasma carboxypeptidases as regulators of the plasminogen system. J. Clin. Invest. 96, 2534-2538
25. Namiranian, S., Naito, Y., Kakkar, V. V. and Scully, M. F. (1995) Bound plasminogen is rate-limiting for cell-surface-mediated activation of plasminogen by urokinase. Biochem. J. 309, 977-982
26. Felez, J., Miles, L. A., Plescia, J. and Plow, E. F. (1990) Regulation of plasminogen receptor expression on human monocytes and monocytoid cell lines J. Cell Biol. 111, 1673-1683
27. Plummer, T. H. J. and Hurwitz, M. Y. (1978) Human plasma carboxypeptidase N. Isolation and characterization. J. Biol. Chem. 253, 3907-3912
28. Tan, F. Deddish, P. A. and Skidgel, R. A. (1995) Human carboxypeptidase M. Methods Enzymol. 248, 663-675
29. Tan, F., Balsitis, S., Black, J. K., Blochl, A., Mao, J. F., Becker, R. P., Schacht, D. and Skidgel, R. A. (2003) Effect of mutation of two critical glutamic acid residues on the activity and stability of human carboxypeptidase M and characterization of its signal for glycosylphosphatidylinositol anchoring. Biochem. J. 370, 567-578
30. Skidgel, R. A., Bennett, C. D., Schilling, J. W., Tan, F. L., Weerasinghe, D. K. and Erdös, E. G. (1988) Amino acid sequence of the N-terminus and selected tryptic peptides of the active subunit of human plasma carboxypeptidase N: comparison with other carboxypeptidases. Biochem. Biophys. Res. Commun. 154, 1323-1329
31. Gebhard, W., Schube, M. and Eulitz, M. (1989) cDNA cloning and complete primary structure of the small, active subunit of human carboxypeptidase N (kininase 1). Eur. J. Biochem. 178, 603-607
32. Tan, F., Weerasinghe, D. K., Skidgel, R. A., Tamei, H., Kaul, R. K., Roninson, I. B., Schilling, J. W. and Erdös, E. G. (1990) The deduced protein sequence of the human carboxypeptidase N high molecular weight subunit reveals the presence of leucine-rich tandem repeats. J. Biol. Chem. 265, 13-19
33. Erratum (1990) J. Biol. Chem. 265, 12749
34. Tan, F., Chan, S. J., Steiner, D. F., Schilling, J. W. and Skidgel, R. A. (1989) Molecular cloning and sequencing of the cDNA for human membrane-bound carboxypeptidase M. Comparison with carboxypeptidases A, B, H, and N. J. Biol. Chem. 264, 13165-13170
35. Gorris-Ruth, F. X., Companys, V., Qian, Y., Fricker, L. D., Vendrell, J., Aviles, F. X. and Coll, M. (1999) Crystal structure of avian carboxypeptidase D domain II: a prototype for the regulatory metallocarboxypeptidase subfamily. EMBO J. 18, 5817-5826
36. Reverter, D., Maskos, K., Tan, F., Skidgel, R. A. and Bode, W. (2004) Crystal structure of human carboxypeptidase M, a membrane-bound enzyme that regulates peptide hormone activity. J. Mol. Biol. 338, 257-269
37. Tan, F., Rehli, M., Krause, S. W. and Skidgel, R. A. (1997) Sequence of human carboxypeptidase D reveals it to be a member of the regulatory carboxypeptidase family with three tandem active site domains. Biochem. J. 327, 81-87
38. Kobe, B. and Kajava, A. V. (2001) The leucine-rich repeat as a protein recognition motif. Curr. Opin. Struct. Biol. 11, 725-732
39. Bateman, A., Coin, L., Durbin, R., Finn, R. D., Hollich, V., Griffiths-Jones, S., Khanna, A., Marshall, M., Moxon, S., Sonnhammer, E. L. et al. (2004) The Pfam protein families database. Nucleic Acids Res. 32, D138-D141
40. Enkhbayar, P., Kamiya, M., Osaki, M., Matsumoto, T. and Matsushima, N. (2003) Structural principles of leucine-rich repeat (LRR) proteins. Proteins 54, 394-403
41. Papageorgiou, A. C., Shapiro, R. and Acharya, K. R. (1997) Molecular recognition of human angiogenin by placental ribonuclease inhibitor - an X-ray crystallographic study at 2.C A resolution. EMBO J. 16, 5162-5177
42. Morell, A. G., Irvine, R. A., Sternlieb, I., Scheinberg, I. H. and Ashwell, G. (1968) Physical and chemical studies on ceruloplasmin. V. Metabolic studies on sialic acid-free ceruloplasmin in vivo. J. Biol. Chem. 243, 155-159
43. Lijnen, H. R., Bachmann, F., Collen, D., Ellis, V., Pannekoek, H., Rijken, D. C. and Thorsen, S. (1994) Mechanisms of plasminogen activation. J. Intern. Med. 236, 415-424
44. Collen, D. (2001) Ham-Wasserman lecture: role of the plasminogen system in fibrin-homeostasis and tissue remodeling. Hematology (Am. Soc. Hematol. Educ. Program), 1-9
45. Collen, D. (1999) The plasminogen (fibrinolytic) system. Thromb. Haemostasis 82, 259-270
46. Mammen, E. F. (2000) Disseminated intravascular coagulation (DIC). Clin. Lab. Sci. 13, 239-245
47. Deitcher, S. R. and Jaff, M. R. (2002) Pharmacologic and clinical characteristics of thrombolytic agents. Rev. Cardiovasc. Med. 3 (Suppl. 2), S25-S33
48. Novokhatny, V. V., Jesmok, G. J., Landskroner, K. A., Warder, V. J. and Zimmerman, T. P. (2004) Locally delivered plasmin: why should it be superior to plasminogen activators for direct thrombolysis? Trends Pharmacol. Sci. 25, 72-75
49. Huey, R., Bloor, C. M., Kawahara, M. S. and Hugli, T. E. (1983) Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue. Am. J. Pathol. 112, 48-60
50. Mathews, K. P., Curd, J. G. and Hugli, T. E. (1986) Decreased synthesis of serum carboxypeptidase N (SCPN) in familial SCPN deficiency. J. Clin. Immunol. 6, 87-91
51. Hoffmeister, H. M., Ruf, M., Wendel, H. P., Heller, W. and Seipel, L. (1998) Streptokinase-induced activation of the kallikrein-kinin system and of the contact phase in patients with acute myocardial infarction. J. Cardiovasc. Pharmacol. 31, 764-772
52. Hoffmeister, H. M., Szabo, S., Helber, U. and Seipel, L. (2001) The thrombolytic paradox. Thromb. Res. 103 (Suppl. 1), S51-S55
53. Agostoni, A., Gardinali, M., Frangi, D., Cafaro, C., Conciato, L., Sponzilli, C., Salvioni, A., Cugno, M. and Cicardi. M. (1994) Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. A comparison between streptokinase and recombinant tissue-type plasminogen activator. Circulation 90, 2666-2670
54. Shariat-Madar, Z. and Schmaier, A. H. (2004) The plasma kallikrein/kinin and renin angiotensin systems in blood pressure regulation in sepsis. J. Endotoxin Res. 10, 3-13
55. Mojcik, C. F. and Levy, J. H. (2001) Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. Ann. Thorac. Surg. 71, 745-754
56. Schmaier, A. H. (2000) Plasma kallikrein/kinin system: a revised hypothesis for its activation and its physiologic contributions. Curr. Opin. Hematol. 7, 261-265
57. Morel, D. R., Zapol, W. M., Thomas, S. J., Kitain, E. M., Robinson, D. R., Moss, J., Chenoweth, D. E. and Lowenstein, E. (1987) C5a and thromboxane generation associated with pulmonary vaso- and broncho-constriction during protamine reversal of heparin. Anesthesiology 66, 597-604
58. Colman, R. W. (1987) Humoral mediators of catastrophic reactions associated with protamine neutralization. Anesthesiology 66, 595-596
59. Lock, R. and Hessel, II, E. A. (1990) Probable reversal of protamine reactions by heparin administration. J. Cardiothorac. Anesth. 4, 604-608